🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Intravenous infusion of CART cells in the treatment of solid tumors may be ...
Status
Unknown
Location
Renji Hospital, Shanghai Jiao Tong University School of Medicine
Start Date
2016-03
Trial ID
NCT02715362
Treatments Being Tested
The purpose of this study is to collect the date on the safety and potentia...
Status
Unknown
Location
Shanghai Tumor Hospital
Start Date
2016-07
Trial ID
NCT02959151
Treatments Being Tested
In this single-center, single-arm, prospective, open-label Phase 1/2 study,...
Status
Not Yet Recruiting
Location
Biotherapeutic Department of Chinese PLA General Hospital
Start Date
2024-11-15
Trial ID
NCT06641453
Treatments Being Tested
A study that aimed to assess the safety and anti-tumor activity of CCAR031 ...
Status
Recruiting
Location
the First Affiliated Hospital, School of Medicine, Zhejiang University
Start Date
2022-02-21
Trial ID
NCT05155189
Treatments Being Tested
This is a Phase I clinical study evaluating the safety, pharmacokinetics, a...
Status
Recruiting
Location
Beijing GoBroad Hospital
Start Date
2025-02-24
Trial ID
NCT06891742
Treatments Being Tested
A Phase I/II study to evaluate AZD5851 in patients with GPC3+ advanced/recu...
Status
Active Not Recruiting
Location
Research Site
Start Date
2023-12-14
Trial ID
NCT06084884
Treatments Being Tested
The goal of this clinical trial is to evaluate the safety and efficacy of a...
Status
Unknown
Location
Department of Oncology, Xinqiao Hospital
Start Date
2017-06-01
Trial ID
NCT03084380
A Phase I Clinical Trial for Evaluating the Safety, Tolerance and Efficacy ...
Status
Terminated
Location
Beijing Gobroad Boren Hospital
Start Date
2022-05-19
Trial ID
NCT05352542
Treatments Being Tested
In this study, CART cells are targeted to GPC3 by intratumor injected that ...
Status
Unknown
Location
302 Military Hospital
Start Date
2017-04-01
Trial ID
NCT03130712
Treatments Being Tested